Literature DB >> 1219088

Multiple crossed false localizing signs in a posterior fossa tumour.

R S Maurice-Williams.   

Abstract

Involvement of the lower cranial nerves as false localizing signs of intracranial tumour is very rare. A laterally placed posterior fossa meningioma gave rise to contralateral cerebellar ataxia and palsies of the fifth, ninth, and tenth cranial nerves.

Entities:  

Mesh：

Year:  1975        PMID： 1219088      PMCID： PMC492193          DOI： 10.1136/jnnp.38.12.1232

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  4 in total

1.  False localizing signs. A review of the concept and analysis of the occurrence in 250 cases of intracranial meningioma.

Authors:  M M GASSEL
Journal:  Arch Neurol       Date:  1961-05

2.  Certain false localizing signs of intracranial tumor: report of case.

Authors:  H W DODGE; E C CLARK; H P WAGENER; A P HUSTEAD
Journal:  Proc Staff Meet Mayo Clin       Date:  1955-10-05

3.  "False" localizing signs in intracranial tumor; report of a patient with left trigeminal palsy due to right temporal meningioma.

Authors:  G EHNI
Journal:  AMA Arch Neurol Psychiatry       Date:  1950-11

4.  Dysphagia in unilateral cerebral lesions.

Authors:  J C Meadows
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154
  4 in total
  3 in total

Review 1.  False localising signs.

Authors:  A J Larner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

2.  False localizing signs in traumatic brain injury.

Authors:  Cristin McKenna; Jonathan Fellus; Anna M Barrett
Journal:  Brain Inj       Date:  2009-07       Impact factor: 2.311

3.  Bilateral abducens and facial nerve palsies as a localizing sign due to reduction in intracranial pressure after fourth ventriculoperitoneal shunting.

Authors:  Boby Varkey Maramattom; Dilip Panikar
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.